Central nervous system fungal infections: observations from a large tertiary hospital in northern India
Related Experiment Video
Updated: May 23, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Prahlad K Sethi1, Laxmi Khanna, Anuradha Batra
1Department of Neurology, Sir Gangaram Hospital, New Delhi, India. sethinitinmd@hotmail.com
Objective:
To report our observations regarding fungal infections of the brain over two years from a large tertiary hospital in northern India. To identify fungal infections in immunocompetent and immunocompromised patients and to compare the two groups with respect to their age of occurrence, demographic data, clinical profile, radiological findings, response to treatment and outcome.
Methods:
All consecutive cases of central nervous system (CNS) fungal infections admitted to the hospital over two years were included in this study. The patients were categorized as immunocompetent and immunocompromised, the predisposing factors, symptoms and clinical presentation were studied in detail and the outcomes of the two groups were compared.
Results:
Of the 50 cases, 25(50%) were that of mucormycosis, 17(34%) were cryptococcosis and 8(16%) cases were that of aspergillosis. 14(28%) cases were immunocompetent and 36(72%) were immunocompromised. The outcome studied was as follows: 28% died of which 4% were HIV positive, 12% were diabetics with severe rhinorbital involvement, 2% had idiopathic thrombocytopenic purpura (ITP), 6% had advanced cancer and 4% had no predisposing illness.
Conclusions:
We observed fungal infections of the brain in both immunocompetent and immunocompromised patients. In immunocompetent patients, early diagnosis and appropriate treatment frequently leads to recovery from the illness. The mortality and morbidity of fungal infections are less in the immunocompetent group of patients.
Insights
Fungal brain infections affect both immunocompetent and immunocompromised individuals. Early diagnosis and treatment significantly improve outcomes, with lower mortality and morbidity observed in immunocompetent patients with central nervous system fungal infections.
Area of Science:
- Neurology
- Infectious Diseases
- Mycology
Background:
- Fungal infections of the central nervous system (CNS) pose a significant diagnostic and therapeutic challenge.
- Understanding the spectrum and outcomes of these infections in diverse patient populations is crucial for effective management.
Purpose of the Study:
- To investigate the clinical characteristics, treatment responses, and outcomes of CNS fungal infections.
- To compare the presentation and prognosis of fungal infections in immunocompetent versus immunocompromised patients.
Main Methods:
- A retrospective study of all consecutive CNS fungal infection cases over two years at a tertiary hospital in northern India.
- Patients were classified as immunocompetent or immunocompromised, with detailed analysis of demographics, clinical presentation, radiological findings, and treatment outcomes.
Main Results:
- Mucormycosis (50%), cryptococcosis (34%), and aspergillosis (16%) were the most common fungal CNS infections.
- 36% of patients were immunocompromised, while 14% were immunocompetent.
- Overall mortality was 28%, with higher rates associated with specific comorbidities and disease severity.
Conclusions:
- CNS fungal infections occur in both immunocompetent and immunocompromised hosts.
- Prompt diagnosis and targeted therapy are associated with favorable outcomes, particularly in immunocompetent individuals.
- Immunocompetent patients generally experience lower mortality and morbidity from fungal brain infections.
Related Concept Videos
Fungal Phylum Microsporidia
Bacterial Meningitis I: Introduction
Antifungal Agents
Brain Abscess l: Introduction
Bacterial Meningitis II: Pathophysiology
Infectious Diseases and Their Occurrence
